Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: Therapeutic and endocrine effects in postmenopausal advanced breast cancer patients
- 1 October 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (10) , 1451-1459
- https://doi.org/10.1016/0277-5379(87)90086-1
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patientsCancer Chemotherapy and Pharmacology, 1985
- Combination endocrine therapy in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetateCancer, 1984
- Additive hormonal therapy in women with advanced breast cancerCancer, 1984
- The biology and physiology of ‘Nolvadex’ (tamoxifen) in the treatment of breast cancerBreast Cancer Research and Treatment, 1982
- Reporting results of cancer treatmentCancer, 1981
- Cancer of the BreastNew England Journal of Medicine, 1980
- Cancer of the BreastNew England Journal of Medicine, 1980
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel- Haenszel ProcedureJournal of the American Statistical Association, 1963